Sanofi
SNY
503 hedge funds and large institutions have $13.7B invested in Sanofi in 2014 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 203 increasing their positions, 138 reducing their positions, and 33 closing their positions.
47% more repeat investments, than reductions
Existing positions increased: 203 | Existing positions reduced: 138
40% more funds holding in top 10
Funds holding in top 10: 10 → 14 (+4)
36% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 33
11% more call options, than puts
Call options by funds: $52.4M | Put options by funds: $47.2M
8% more capital invested
Capital invested by funds: $12.7B → $13.7B (+$1B)
2% more funds holding
Funds holding: 493 → 503 (+10)
0.25% more ownership
Funds ownership: 18.13% → 18.38% (+0.25%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MNA
Manning & Napier Advisors
Fairport,
New York
|
+$111M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$67.6M |
| 3 |
Primecap Management
Pasadena,
California
|
+$47.2M |
| 4 |
Harris Associates
Chicago,
Illinois
|
+$44.8M |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
+$40M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SI
Scharf Investments
Los Gatos,
California
|
-$101M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$62.6M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$36.3M |
| 4 |
First Eagle Investment Management
New York
|
-$30.9M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$30M |
SNY Hedge Fund Activity: Q3 2014 in Review
503 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q3 2014, worth a combined $13.7B — up 7.9% from $12.7B a quarter earlier.
Buyers outnumbered sellers: 45 funds opened new SNY positions and 33 closed out — a net gain of 12 holders — while 203 added to existing stakes and 138 trimmed.
The largest buyer was Manning & Napier Advisors, adding an estimated $111M. The largest seller was Scharf Investments, cutting an estimated $101M.
- 503 institutional investors held Sanofi (SNY) as of Q3 2014, up from 493 in Q2 2014.
- Funds reported $13.7B of Sanofi stock for Q3 2014, up 7.9% quarter-over-quarter.
- 45 funds opened new Sanofi positions in Q3 2014 and 33 closed out, a net change of +12 holders.
- The largest Sanofi buyer in Q3 2014 was Manning & Napier Advisors, an estimated $111M added.
- The largest Sanofi seller in Q3 2014 was Scharf Investments, an estimated $101M sold.
Based on aggregated 13F filings for Q3 2014.